Table 3.
[84] Xiao et al., 2011 | Canada/Overweight and obese patients without history of diabetes | Patients were treated in random order with: oral placebo followed by NaCl infusion (SAL), oral placebo followed by intralipid infusion (IH), oral ALA 1800 mg per day followed by NaCl infusion (ALA) and oral ALA 1800 mg per day followed by intralipid infusion (ALA + IH) | 2 weeks each phase | No medications | Insulin secretion rate was similar between treatment groups |
*** Insulin secretion rate (ISR) (pmol/min) is derived from deconvolution of C-peptide concentrations measured during hyperglycaemic clamp.